Private Equity

Other Private Equity/Strategic Investments

Suburban Diagnostics in sale talks with Lal Path, Metropolis, PE funds

Economic Times  

Pathology services provider Suburban Diagnostics is in talks with Dr. Lal PathLabs, Metropolis Healthcare, PharmEasy and a clutch of private equity funds for a complete sale. The Mumbai-based diagnostics chain, backed by Sequoia Capital, has received bids ranging from INR 800 crore to INR 1,200 crore for the buyout. Sequoia Capital had in 2012 first invested INR 40 crore in the company, and has been drawing up an exit plan for a few years now. Suburban has explored several options including an IPO in the past.